Table 3. Inclusion criteria for TARGIT-US trial.
Age ≥45 years |
Invasive breast cancers other than lobular |
T1 and T2 (<3.5 cm), N0-1, M0 |
ECOG performance status of 0–3 |
Informed consent |
ECOG = Eastern Cooperative Oncology Group
Age ≥45 years |
Invasive breast cancers other than lobular |
T1 and T2 (<3.5 cm), N0-1, M0 |
ECOG performance status of 0–3 |
Informed consent |
ECOG = Eastern Cooperative Oncology Group